Cargando…
Challenges and recent progress in drug discovery for tropical diseases
Infectious tropical diseases have a huge effect in terms of mortality and morbidity, and impose a heavy economic burden on affected countries. These diseases predominantly affect the world’s poorest people. Currently available drugs are inadequate for the majority of these diseases, and there is an...
Autores principales: | De Rycker, Manu, Baragaña, Beatriz, Duce, Suzanne L., Gilbert, Ian H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129172/ https://www.ncbi.nlm.nih.gov/pubmed/30046073 http://dx.doi.org/10.1038/s41586-018-0327-4 |
Ejemplares similares
-
Anti-trypanosomatid drug discovery: progress and challenges
por: De Rycker, Manu, et al.
Publicado: (2022) -
Comment on “The translational challenge in Chagas disease drug development” by Kratz et al.
por: De Rycker, Manu
Publicado: (2022) -
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
por: MacLean, Lorna M., et al.
Publicado: (2018) -
A Static-Cidal Assay for Trypanosoma brucei to Aid Hit Prioritisation for Progression into Drug Discovery Programmes
por: De Rycker, Manu, et al.
Publicado: (2012) -
Live-imaging rate-of-kill compound profiling for Chagas disease drug discovery with a new automated high-content assay
por: Svensen, Nina, et al.
Publicado: (2021)